Spirulina for Anti-Inflammatory

Research suggests that spirulina possesses meaningful anti-inflammatory properties, with multiple review articles, systematic reviews, and preclinical studies consistently pointing to its ability to reduce inflammatory markers, suppress pro-inflammatory signaling pathways, and modulate immune cell behavior, effects attributed largely to bioactive compounds such as phycocyanin, polysaccharides, and beta-carotene. Studies indicate these anti-inflammatory effects have been observed across a range of contexts, including exercise-induced muscle damage, liver injury, neurological stress, joint conditions such as rheumatoid arthritis and osteoarthritis, and chronic low-grade inflammation associated with obesity, though much of this evidence comes from animal models and laboratory studies rather than large, well-controlled human trials. A 2022 systematic review of clinical studies spanning multiple disease conditions generally supported anti-inflammatory benefits in humans, while another 2022 systematic review focused on athletes found the evidence inconsistent and limited, underscoring that results can vary depending on the population studied, the outcome measured, and the quality of individual trials. Overall, the body of research is encouraging in direction but remains preliminary in strength, with authors across multiple reviews consistently calling for more rigorous and larger-scale human studies before firm conclusions can be drawn.